Your browser doesn't support javascript.
loading
Lifetime ovulatory years and risk of epithelial ovarian cancer: a multinational pooled analysis.
Fu, Zhuxuan; Brooks, Maria Mori; Irvin, Sarah; Jordan, Susan; Aben, Katja K H; Anton-Culver, Hoda; Bandera, Elisa V; Beckmann, Matthias W; Berchuck, Andrew; Brooks-Wilson, Angela; Chang-Claude, Jenny; Cook, Linda S; Cramer, Daniel W; Cushing-Haugen, Kara L; Doherty, Jennifer A; Ekici, Arif B; Fasching, Peter A; Fortner, Renée T; Gayther, Simon A; Gentry-Maharaj, Aleksandra; Giles, Graham G; Goode, Ellen L; Goodman, Marc T; Harris, Holly R; Hein, Alexander; Kaaks, Rudolf; Kiemeney, Lambertus A; Köbel, Martin; Kotsopoulos, Joanne; Le, Nhu D; Lee, Alice W; Matsuo, Keitaro; McGuire, Valerie; McLaughlin, John R; Menon, Usha; Milne, Roger L; Moysich, Kirsten B; Pearce, Celeste Leigh; Pike, Malcolm C; Qin, Bo; Ramus, Susan J; Riggan, Marjorie J; Rothstein, Joseph H; Schildkraut, Joellen M; Sieh, Weiva; Sutphen, Rebecca; Terry, Kathryn L; Thompson, Pamela J; Titus, Linda; van Altena, Anne M.
Afiliação
  • Fu Z; Department of Epidemiology, University of Pittsburgh School of Public Health, Pittsburgh, PA, USA.
  • Brooks MM; Department of Epidemiology, University of Pittsburgh School of Public Health, Pittsburgh, PA, USA.
  • Irvin S; Department of Biostatistics, University of Pittsburgh School of Public Health, Pittsburgh, PA, USA.
  • Jordan S; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
  • Aben KKH; The School of Public Health, The University of Queensland, Brisbane, Queensland, Australia.
  • Anton-Culver H; Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Bandera EV; Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands.
  • Beckmann MW; Department of Medicine, Genetic Epidemiology Research Institute, University of California Irvine, Irvine, CA, USA.
  • Berchuck A; Cancer Prevention and Control Program, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.
  • Brooks-Wilson A; Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-European Metropolitan Region of Nuremberg (EMN), Friedrich-Alexander University Erlangen-Nuremberg, University Hospital Erlangen, Erlangen, Germany.
  • Chang-Claude J; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, NC, USA.
  • Cook LS; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC, Canada.
  • Cramer DW; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Cushing-Haugen KL; Cancer Epidemiology Group, University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Doherty JA; Epidemiology, School of Public Health, University of Colorado, Aurora, CO, USA.
  • Ekici AB; Community Health Sciences, University of Calgary, Calgary, AB, Canada.
  • Fasching PA; Department of Obstetrics and Gynecology, Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • Fortner RT; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
  • Gayther SA; Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Gentry-Maharaj A; Department of Population Health Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
  • Giles GG; Institute of Human Genetics, Comprehensive Cancer Center Erlangen-EMN, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg (FAU), Erlangen, Germany.
  • Goode EL; Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-European Metropolitan Region of Nuremberg (EMN), Friedrich-Alexander University Erlangen-Nuremberg, University Hospital Erlangen, Erlangen, Germany.
  • Goodman MT; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Harris HR; Center for Bioinformatics and Functional Genomics and the Cedars Sinai Genomics Core, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Hein A; MRC Clinical Trials Unit, Institute of Clinical Trials & Methodology, University College London, London, UK.
  • Kaaks R; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australia.
  • Kiemeney LA; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.
  • Köbel M; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia.
  • Kotsopoulos J; Department of Quantitative Health Sciences, Division of Epidemiology, Mayo Clinic, Rochester, MN, USA.
  • Le ND; Cancer Prevention and Control Program, Cedars-Sinai Cancer, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Lee AW; Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Matsuo K; Department of Epidemiology, University of Washington, Seattle, WA, USA.
  • McGuire V; Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-European Metropolitan Region of Nuremberg (EMN), Friedrich-Alexander University Erlangen-Nuremberg, University Hospital Erlangen, Erlangen, Germany.
  • McLaughlin JR; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Menon U; Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Milne RL; Department of Pathology and Laboratory Medicine, University of Calgary, Foothills Medical Center, Calgary, AB, Canada.
  • Moysich KB; Women's College Research Institute, Women's College Hospital, University of Toronto, Toronto, ON, Canada.
  • Pearce CL; Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.
  • Pike MC; Cancer Control Research, BC Cancer, Vancouver, BC, Canada.
  • Qin B; Department of Health Science, California State University, Fullerton, Fullerton, CA, USA.
  • Ramus SJ; Division of Cancer Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Japan.
  • Riggan MJ; Division of Cancer Epidemiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Rothstein JH; Department of Epidemiology and Population Health, Stanford University School of Medicine, Stanford, CA, USA.
  • Schildkraut JM; Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.
  • Sieh W; MRC Clinical Trials Unit, Institute of Clinical Trials & Methodology, University College London, London, UK.
  • Sutphen R; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australia.
  • Terry KL; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.
  • Thompson PJ; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia.
  • Titus L; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, NY, USA.
  • van Altena AM; Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, MI, USA.
J Natl Cancer Inst ; 115(5): 539-551, 2023 05 08.
Article em En | MEDLINE | ID: mdl-36688720

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Pregnancy Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Pregnancy Idioma: En Ano de publicação: 2023 Tipo de documento: Article